論文專著:
發(fā)表論文多篇,成果多在影響因子高于5的國際刊物發(fā)表,影響因子之和接近80,14篇論文被SCI收錄,他引74次,15篇被CA收錄,他引194次。
出版專著:
資料更新中……
發(fā)表論文:
英文:
1. Zhuohan Zhang, Bin Zeng, Zhiqian Zhang, Guohui Jiao, Haijie Li, Zhizi Jing, Jiangbo Ouyang, Xin Yuan1, Limin Chai, Yongzhe Che, Yuan Zhang and Rongcun Yang1, Suppressor of Cytokine Signaling 3 Promotes Bone Marrow Cells to Differentiate into CD8+ T Lymphocytes in Lung Tissue via Up-Regulating Notch1 Expression. Cancer Research 69, 1578-1586, February 15, 2009. Published Online First February 3, 2009;
2. Rongcun Yang and Richard Roden. The terminology issue for myeloid-derived suppressor cells. Cancer Research (2007; 67(1):3630)
3. Rongcun Yang, Zhong Cai, Yuan Zhang, William H. Yutzy IV, Katherine F. Roby and Richard B.S. Roden. CD80 in Immune Suppression by Mouse Ovarian Carcinoma-Associated Gr-1+CD11b+ Myeloid Cells (Cancer Research,2006July,6807-15 SCI-IF 8.2;Rongcun Yang:corresponding author。
4. Zhuohan Zhang, Xiaoying Yang, Yuan Zhang, Bin Zeng, Shujing Wang, Tianhui Zhu, Richard B.S. Roden, Yongsheng Chen, and Rongcun Yang . Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor Growth. Clin. Cancer Res. 2006 12: 4933-4939. SCI-IF 6.8)
5. Hongsheng Dai, Bin Zeng, Rongcun Yang, Regulatory T cells in cancer. International Journal of Immunology, accepted, Review, (article in Chinese)
6. Hongsheng Dai, Bin Zeng, Rongcun Yang, Dendritic cells dysfunction: a mechanism for immunotolerance to tumor, International Journal of Immunology, accepted, Review, (article in Chinese)
7. Bin Zeng1, Lina Wang1,Zhuohan Zhang1, Si Chen1, Xiaohong Zhao1, Yuan Zhang1, Richard B.S. Roden2 and Rongcun Yang1,2。Suppressors of cytokine signaling (SOCS)3 inhibited TLR3 induced dendritic cell activation via type I IFN receptor TYK2 (Corresponding authors: Rongcun Yang1,2 and Richard B.S. Roden) Submitted to J. B.C)
8. Xiaohong Zhao1, Bin Zeng1, Zhuohan Zhang1, Si Chen1, Yuan Zhang1, and Richard B.S. Roden2 and Rongcun Yang1,2。 B7-H1 on Myeloid-Derived Suppressor Cells in Immune Suppression by a Mouse Model of Ovarian Cancer (Corresponding authors: Rongcun Yang1,2 and Richard B.S. Roden. Submitted to cancer Research)
9. Rongcun Yang, Francisco Martinez Murillo2, William H. Yutzy IV1, Satoshi Uematsu, Kiyoshi Takeda5, Shizuo Akira5, Raphael P Viscidi3, and Richard B.S. Roden1,4*. B Lymphocyte Activation by Human Papillomavirus-Like Particles Directly Induces Ig Class Switch Recombination via TLR4-MyD88。 Journal of Immunology . 2005 Jun 15;174(12):7912-9, SCI-IF 6.7)
10. Rongcun Yang, Francisco Martinez Murillo2, William H. Yutzy IV1, Satoshi Uematsu5, Kiyoshi Takeda5, Shizuo Akira5, Raphael P Viscidi3, and Richard B.S. Roden1,4*. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.Journal of Virology, 2005,79(11)6741-6750, SCI-IF 5.2)
11. Bossis I, Roden RB, Gambhira R, Rongcun Yang, Tagaya M, Howley PM, Meneses PI. Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection. J Virol. 2005 Jun;79(11):6723-31, SCI-IF 5.2)
12. Rongcun Yang, Murillo FM, Lin KY, Yutzy WH 4th, Uematsu S, Takeda K,Akira S, ViscidiRP,Roden RB. Human papillomavirus type-16 virus-like particles activate complementary defense responses in key dendritic cell subpopulations. J Immunol. 2004 Aug 15;173(4):2624-31, SCI-IF 6.7)
13. Rongcun Yang, Murillo FM, Cui H, Blosser R, Uematsu S, Takeda K, Akira S, Viscidi RP, Roden RB. Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88. J.virol. 2004 Oct;78(20):11152-60, SCI-IF 5.2)
14. Rongcun Yang, William H. Yutzy IV, Raphael Viscidi and Richrard B. S. Roden. Interaction of L2 with b-actin directs intracellular transport of papillomavirus and infection. The Journal of Biological Chemistry, 2003, 278, 12546-12553, SCI-IF 6.48)
15. Rongcun Yang, Patricia m. Day, William H. Yutzy IV, Ken-Yu Lin, Chien-Fu Hung and Richard B. S. Roden. Cell surface binding motifs of L2 that facilitates papillomavirus infection. Journal of Virology, 2003, 77(6), 3531-3541, SCI-IF 5.2)
16. Rongcun Yang and Richard B. S. Roden. Genetic polymorphism and tumor immunotherapy. Current Pharmacogenomics, 2003 (1), 37-57 (Review )
17. Rongcun Yang, Z. Yan, F. Chen, G. K. Hansson, R. Kiessling. Hyaluronic acid and chondroitin sulphate A rapidly promote differentiation of Immature DC with upregulation of costimulatory and antigen-presentating molecules, and enhancement of NF-kB and protein kinase activity, Scand J. Immunol. 55, 2-13, 2002, SCI-IF 1.94)
18. Rongcun Yang, Dawei Xu, Anju Zhang, Astrid Gruber. Immature dendritic cells kill ovarian carcinoma cells by a FAS/FASL pathway, enabling them to sensitize tumor-specific CTLs. International Journal of Cancer: 2001, 94, 407-413, SCI-IF 4.38)
19. *Seliger B and Rongcun Yang (Both are equal contribution to this paper), Atkins D, Hammers S, Huber C, Storkel S, Kiessling R. HER2/neu is expressed in human renal cell carcinoma at heterogeneous levelsindependently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes. International Journal of Cancer, 2000, 87(3): 349-59, SCI-IF 4.38)
20. Rongcun Yang, Flavio Salazar-Onfray, J. Charo, K. Evrin, H. maes, K. Kono, C. Hising, E. Gerdin, L. Lan, E. Appella, A. Sette, E. Celis and R. Kiessling. Identification of new HER2/neu derived peptide epitopes which can elicit specific CTL against autologous and allogenetic carcinomas. Journal of Immunology, 1999, 163: 1037-1044, SCI-IF 6.7)
21. Rongcun Yang, H. Maes, M. Corsi, T. Wen and R. Kiessling. Interferon-g impairs the ability of monocyte-derived dendritic cells to present tumor-specific and allo-specific antigens and reduces their expression of CD1a, CD80 and CD4. Cytokine 10(10): 747-755, 1998, SCI-IF 2.18)
22. K. Kono, Rongcun Yang, J. Charo, F. Ichihara, E. Celis, A. Sette, E. Appella, T. Sekikawa, Y. Matsumoto and R. Kiessling. Identification of HER2/neu-derived peptide epitopes recognized by gastric cancer-specific CTLs. International Journal of Cancer, 78: 202-208, 1998, SCI-IF 4.38)
23. R. Madiyalakan, Rongcun Yang, B. C. Schultes, R. P. Baum, and A. A. Noujaim. OVAERXTM MAb-B43.13: IFN-g could improve the ovarian tumor cell sensitivity to CA-125-specific allogenetic cytotoxic T cells. Hybridoma 16 (1): 41-45, 1997(影響因子0.6)
24. Yunnuan Jia, Rongcun Yang. Application of multilevel Fuzzy synthetic Judgment in evauation effects of tumor vaccine in the immuno-biological therapeutics against tumors。 Journal of mathematics for technology(17(5), 12-16, 2000 (Chinese)
25. Rongcun Yang, P. Chen, F.Wang, H.Qie. Effect of liposome encapsulatedprimaquine and immuno-liposome encapsulated primaquine on marine malaria。 Chinese Journal of preventive parasite disease 4(3): 173-75, 1991(Chinese)
26. Rongcun Yang, P. Chen, F.Wang, H。 Qie, H. Jiang. Preparation of primaquine-liposome by double emulsification and evaporation method。 Journal of Capital Institute of Medicien 11(20): 127-130, 1990 (Chinese)
27. Rongcun Yang and Richard B. S. Roden. Genetic polymorphism and tumor immunotherapy. Current Pharmacogenomics, 2003 (1), 37-57 (Review by Rongcun Yang, 通信作者)
中文:
1 微小RNA(microRNA)與免疫細胞分化及功能調節(jié) 劉喬飛; 楊榮存 南開大學醫(yī)學院免疫系 【期刊】中國免疫學雜志 2010-06-20
2 Th17細胞的分化調節(jié) 焦國慧; 楊榮存 南開大學醫(yī)學院免疫學教研室 【期刊】中國免疫學雜志 2009-01-20
3 人RGS1基因克隆表達及其功能分析 劉昱; 焦國慧; 張灼寒; 曾斌; 陳思; 張圓; 楊榮存 南開大學醫(yī)學院免疫學教研室 【期刊】免疫學雜志 2009-01-15
4 Prosaposin基因對TLR3信號途徑的調節(jié) 俞銀燕; 楊曙光; 曾斌; 焦國慧; 張圓; 楊榮存 南開大學醫(yī)學院免疫學教研室 【期刊】免疫學雜志 2009-01-15
5 SerpinH1對小鼠腫瘤細胞增殖的影響 俞銀燕; 曾彬; 柴立民; 楊曙光; 李長林; 張園; 楊榮存 南開大學醫(yī)學院免疫學教研室 【期刊】腫瘤防治研究 2009-09-25
6 不同Toll樣受體介導的樹突狀細胞因子表達 楊曙光; 焦國慧; 俞銀燕; 楊榮存 南開大學醫(yī)學院免疫學教研室 【期刊】免疫學雜志 2009-09-15
7 跨膜蛋白受體在LRRC19調節(jié)機體先天免疫應答反應中的作用 柴立民; 車永哲; 楊榮存 南開大學醫(yī)學院分子免疫學實驗室; 南開大學醫(yī)學院解剖學教研室 【期刊】解放軍醫(yī)學雜志 2010-01-01
8 體外抑制腫瘤JAK/STAT通路探討STAT4對腫瘤免疫的影響 王悅; 李玉皓; 李小潔; 張園; 楊榮存 【會議】中國免疫學會第五屆全國代表大會暨學術會議論文摘要 2006-11-01
9 體外抑制腫瘤JAK/STAT通路探討STAT1和STAT4對腫瘤免疫的影響 王悅; 李玉皓; 李小潔; 張園; 彭茜; 楊曙光; 楊榮存 【會議】2006中國微生物學會第九次全國會員代表大會暨學術年會論文摘要集 2006-10-01
10 體外抑制腫瘤JAK/STAT通路探討STAT4對腫瘤免疫的影響 王悅; 李玉皓; 李小潔; 曾彬; 張園; 彭茜; 楊榮存 南開大學醫(yī)學院; 南開大學醫(yī)學院; 南開大學醫(yī)學院 天津 【期刊】南開大學學報(自然科學版) 2007-06-20
11 限制性siRNA干涉文庫的構建以及影響HeLa細胞增殖新功能基因的掃描 曾彬; 寧振飛; 寧一純; 隆艷艷; 袁辛; 經孜之; 楊榮存 南開大學醫(yī)學院腫瘤免疫學系 【期刊】中國生物化學與分子生物學報 2008-12-20
12 小鼠免疫抑制蛋白SOCS3脯氨酸富集區(qū)為其生物學功能所必需 李海潔; 曾彬; 張灼寒; 王麗娜; 張竹紅; 楊榮存 南開大學醫(yī)學院; 南開大學醫(yī)學院; 南開大學醫(yī)學院 天津 【期刊】中國生物化學與分子生物學報 2008-05-20
13 腫瘤相關免疫抑制細胞與免疫逃逸機制研究進展 焦國慧; 楊榮存 南開大學醫(yī)學院免疫學教研室; 南開大學醫(yī)學院免疫學教研室 天津 【期刊】癌癥進展 2008-03-20
14 RGS1對RAW264.7細胞共刺激分子和細胞因子表達的調節(jié) 劉昱; 焦國慧; 曾斌; 陳思; 張圓; 楊榮存 南開大學醫(yī)學院免疫學教研室; 南開大學醫(yī)學院免疫學教研室; 南開大學醫(yī)學院免疫學教研室 天津 【期刊】細胞與分子免疫學雜志 2008-08-18
15 MyD88aa155-171功能區(qū)缺失對免疫相關細胞共刺激分子和細胞因子表達的影響 焦國慧; 代紅勝; 張灼寒; 曾彬; 劉昱; 張園; 楊榮存 南開大學醫(yī)學院 【期刊】中國生物工程雜志 2008-09-15
16 APOE對鼠RAW264.7細胞系內TLR信號通路的調節(jié) 楊曙光; 彭茜; 俞銀燕; 曾彬; 焦國慧; 張圓; 楊榮存 南開大學醫(yī)學院免疫學教研室 【期刊】基礎醫(yī)學與臨床 2008-10-15
17 伯氨喹脂質體的制備及對約氏瘧原蟲紅外期作用的觀察 楊榮存; 孔德芳; 陳佩惠; 王風蕓; 木英華 首都醫(yī)學院寄生蟲學教研室; 首都醫(yī)學院寄生蟲學教研室 【期刊】中國寄生蟲學與寄生蟲病雜志 1988-12-31
18 一種新的磷酸伯氨喹脂質體的合成方法 楊榮存; 孔德芳 首都醫(yī)學院寄生蟲學教研室; 首都醫(yī)學院寄生蟲學教研室 【期刊】首都醫(yī)學院學報 1990-07-02
19 巨噬細胞活性對伯喹脂質體抗瘧效果的影響 楊榮存; 孔德芳; 卞英華; 王風蕓 首都醫(yī)學院寄生蟲學教研室; 首都醫(yī)學院寄生蟲學教研室; 首都醫(yī)學院寄生蟲學教研室 北京 【期刊】中國寄生蟲病防治雜志 1991-10-01